Translesion DNA Polymerases and Cancer

DNA repair has been regarded as an important barrier to carcinogenesis. The newly discovered field of translesion synthesis (TLS) has made it apparent that mammalian cells need distinct polymerases to efficiently and accurately bypass DNA lesions. Perturbation of TLS polymerase activity by mutation, loss of expression, etc. is expected to result in the accumulation of mutations in cells exposed to specific carcinogens. Furthermore, several TLS polymerases can modulate cellular sensitivity to chemotherapeutic agents. TLS genes and TLS gene variations may thus be attractive pharmacologic and/or pharmacogenetic targets. We review herein current data with regards to the potential contribution of the primary TLS polymerase genes to cancer, their interaction with pharmacologic agents, and identify areas of interest for further research.

[1]  M. Kashani-Sabet,et al.  Differential gene expression in human cancer cells resistant to cisplatin. , 1989, Cancer investigation.

[2]  K. Kinzler,et al.  Polymerase delta variants in RER colorectal tumours. , 1995, Nature genetics.

[3]  A. Chapelle,et al.  Polymerase δ variants in RER colorectal tumours , 1995, Nature Genetics.

[4]  R. Eritja,et al.  Abasic translesion synthesis by DNA polymerase beta violates the "A-rule". Novel types of nucleotide incorporation by human DNA polymerase beta at an abasic lesion in different sequence contexts. , 1997, The Journal of biological chemistry.

[5]  Peter Beighton,et al.  de la Chapelle, A. , 1997 .

[6]  Chikahide Masutani,et al.  The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase η , 1999, Nature.

[7]  Robert E. Johnson,et al.  Efficient bypass of a thymine-thymine dimer by yeast DNA polymerase, Poleta. , 1999, Science.

[8]  Robert E. Johnson,et al.  hRAD30 mutations in the variant form of xeroderma pigmentosum. , 1999, Science.

[9]  Y. Kubota,et al.  Neonatal lethality with abnormal neurogenesis in mice deficient in DNA polymerase β , 2000, The EMBO journal.

[10]  F. Hanaoka,et al.  Error-prone bypass of certain DNA lesions by the human DNA polymerase kappa. , 2000, Genes & development.

[11]  L. Prakash,et al.  Eukaryotic polymerases iota and zeta act sequentially to bypass DNA lesions. , 2000, Nature.

[12]  E. G. Frank,et al.  poliota, a remarkably error-prone human DNA polymerase. , 2000, Genes & development.

[13]  Fenghua Yuan,et al.  Preferential Incorporation of G Opposite Template T by the Low-Fidelity Human DNA Polymerase ι , 2000, Molecular and Cellular Biology.

[14]  Robert E. Johnson,et al.  Mismatch Extension Ability of Yeast and Human DNA Polymerase η* , 2001, The Journal of Biological Chemistry.

[15]  M. Tagawa,et al.  DNA polymerase kappa, implicated in spontaneous and DNA damage-induced mutagenesis, is overexpressed in lung cancer. , 2001, Cancer research.

[16]  Zhigang Wang,et al.  Translesion synthesis by yeast DNA polymerase from templates containing lesions of ultraviolet radiation and acetylaminofluorene , 2001, Nucleic Acids Res..

[17]  M. Rols,et al.  Antitumor Activity of 2 (cid:1) ,3 (cid:1) -Dideoxycytidine Nucleotide Analog Against Tumors Up-Regulating DNA Polymerase (cid:1) , 2001 .

[18]  K Bebenek,et al.  Error rate and specificity of human and murine DNA polymerase eta. , 2001, Journal of molecular biology.

[19]  Robert E. Johnson,et al.  Targeting of human DNA polymerase ι to the replication machinery via interaction with PCNA , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Woodgate,et al.  Unique misinsertion specificity of polι may decrease the mutagenic potential of deaminated cytosines , 2001, The EMBO journal.

[21]  E. G. Frank,et al.  5'-Deoxyribose phosphate lyase activity of human DNA polymerase iota in vitro. , 2001, Science.

[22]  Y. Fujii‐Kuriyama,et al.  Expression of human and mouse genes encoding polκ: testis‐specific developmental regulation and AhR‐dependent inducible transcription , 2001, Genes to cells : devoted to molecular & cellular mechanisms.

[23]  Y. Shinkai,et al.  Polκ protects mammalian cells against the lethal and mutagenic effects of benzo[a]pyrene , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Woodgate,et al.  Localization of DNA polymerases η and ι to the replication machinery is tightly co‐ordinated in human cells , 2002, The EMBO journal.

[25]  L. Loeb,et al.  Deregulated DNA polymerase beta induces chromosome instability and tumorigenesis. , 2002, Cancer research.

[26]  M. Goodman Error-prone repair DNA polymerases in prokaryotes and eukaryotes. , 2002, Annual review of biochemistry.

[27]  R. Fuchs,et al.  How DNA lesions are turned into mutations within cells? , 2002, Oncogene.

[28]  A. Sarasin,et al.  Molecular analysis of mutations in DNA polymerase η in xeroderma pigmentosum-variant patients , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Woodgate,et al.  Structure-based interpretation of missense mutations in Y-family DNA polymerases and their implications for polymerase function and lesion bypass. , 2002, DNA repair.

[30]  A. Grollman,et al.  Translesion synthesis by human DNA polymerase kappa on a DNA template containing a single stereoisomer of dG-(+)- or dG-(-)-anti-N(2)-BPDE (7,8-dihydroxy-anti-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene). , 2002, Biochemistry.

[31]  Yanbin Zhang,et al.  trans-Lesion Synthesis Past Bulky Benzo[a]pyrene Diol Epoxide N 2-dG and N 6-dA Lesions Catalyzed by DNA Bypass Polymerases* , 2002, The Journal of Biological Chemistry.

[32]  E. G. Frank,et al.  Translesion replication of benzo[a]pyrene and benzo[c]phenanthrene diol epoxide adducts of deoxyadenosine and deoxyguanosine by human DNA polymerase iota. , 2002, Nucleic acids research.

[33]  E. Dogliotti,et al.  Deregulated DNA polymerase β strengthens ionizing radiation-induced nucleotidic and chromosomal instabilities , 2002, Oncogene.

[34]  E. Friedberg,et al.  DNA damage and repair , 2003, Nature.

[35]  A. Sarasin,et al.  Role of DNA Polymerase η in the UV Mutation Spectrum in Human Cells* , 2003, Journal of Biological Chemistry.

[36]  W. Mcgregor,et al.  Ribozyme-mediated REV1 inhibition reduces the frequency of UV-induced mutations in the human HPRT gene. , 2003, Nucleic acids research.

[37]  T. Kunkel,et al.  Functions of human DNA polymerases eta, kappa and iota suggested by their properties, including fidelity with undamaged DNA templates. , 2003, DNA repair.

[38]  Samuel H. Wilson,et al.  Base excision repair deficiency caused by polymerase beta haploinsufficiency: accelerated DNA damage and increased mutational response to carcinogens. , 2003, Cancer research.

[39]  J. Utikal,et al.  Molecular genetics of Xeroderma pigmentosum variant , 2003, Experimental dermatology.

[40]  Lei Li,et al.  Nucleotide Excision Repair- and Polymerase η-Mediated Error-Prone Removal of Mitomycin C Interstrand Cross-Links , 2003, Molecular and Cellular Biology.

[41]  S. Velasco-Miguel,et al.  Constitutive and regulated expression of the mouse Dinb (Polkappa) gene encoding DNA polymerase kappa. , 2003, DNA repair.

[42]  J. Sweasy,et al.  Is There a Link Between DNA Polymerase Beta and Cancer? , 2004, Cell cycle.

[43]  G. Maga,et al.  Human DNA polymerases lambda and beta show different efficiencies of translesion DNA synthesis past abasic sites and alternative mechanisms for frameshift generation. , 2004, Biochemistry.

[44]  Zhimin Chen,et al.  Altered DNA Polymerase ι Expression in Breast Cancer Cells Leads to a Reduction in DNA Replication Fidelity and a Higher Rate of Mutagenesis , 2004, Cancer Research.

[45]  A. Nakagawara,et al.  Elevated expression of DNA polymerase kappa in human lung cancer is associated with p53 inactivation: Negative regulation of POLK promoter activity by p53. , 2004, International journal of oncology.

[46]  A. Lehmann,et al.  Co-localization in replication foci and interaction of human Y-family members, DNA polymerase pol eta and REVl protein. , 2004, DNA repair.

[47]  T. Kunkel DNA Replication Fidelity* , 2004, Journal of Biological Chemistry.

[48]  A. Sancar,et al.  Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. , 2004, Annual review of biochemistry.

[49]  K. Eckert,et al.  Prostate-cancer-associated I260M variant of DNA polymerase beta is a sequence-specific mutator. , 2005, Biochemistry.

[50]  Down-regulation of DNA polymerases kappa, eta, iota, and zeta in human lung, stomach, and colorectal cancers. , 2005, Cancer letters.

[51]  S. D. Pena,et al.  Up-regulation of the error-prone DNA polymerase {kappa} promotes pleiotropic genetic alterations and tumorigenesis. , 2005, Cancer research.

[52]  Xun Hu,et al.  Down-regulation of DNA polymerases κ, η, ι, and ζ in human lung, stomach, and colorectal cancers , 2005 .

[53]  S. Chaney,et al.  Recognition and processing of cisplatin- and oxaliplatin-DNA adducts. , 2005, Critical reviews in oncology/hematology.

[54]  J. Błasiak,et al.  [Eukaryotic DNA polymerases]. , 2005, Postepy biochemii.

[55]  M. Albertella,et al.  A role for polymerase eta in the cellular tolerance to cisplatin-induced damage. , 2005, Cancer research.

[56]  J. Yokota,et al.  Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk , 2005, International journal of cancer.

[57]  E. Friedberg,et al.  DNA Repair and Mutagenesis , 2006 .

[58]  L. Loeb,et al.  Mutations in DNA polymerase η are not detected in squamous cell carcinoma of the skin , 2006, International Journal of Cancer.

[59]  G. Parmigiani,et al.  The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.

[60]  F. Hanaoka,et al.  A Novel Role of DNA Polymerase η in Modulating Cellular Sensitivity to Chemotherapeutic Agents , 2006, Molecular Cancer Research.

[61]  Translesion synthesis past tamoxifen-derived DNA adducts by human DNA polymerases eta and kappa. , 2006, Biochemistry.

[62]  M. P. Carty,et al.  The human POLH gene is not mutated, and is expressed in a cohort of patients with basal or squamous cell carcinoma of the skin. , 2007, International journal of molecular medicine.

[63]  Karl-Peter Hopfner,et al.  Bypass of DNA Lesions Generated During Anticancer Treatment with Cisplatin by DNA Polymerase η , 2007, Science.

[64]  R. Woodgate,et al.  Evidence that in xeroderma pigmentosum variant cells, which lack DNA polymerase eta, DNA polymerase iota causes the very high frequency and unique spectrum of UV-induced mutations. , 2007, Cancer research.

[65]  M. Lathrop,et al.  Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers. , 2007, Carcinogenesis.

[66]  Samuel H. Wilson,et al.  The X family portrait: structural insights into biological functions of X family polymerases. , 2007, DNA repair.

[67]  F. Ye,et al.  REV1 genetic variants associated with the risk of cervical carcinoma , 2008, European Journal of Epidemiology.

[68]  T. Kunkel,et al.  Low-fidelity DNA synthesis by human DNA polymerase theta , 2008, Nucleic acids research.

[69]  John D. Storey,et al.  Mapping the Genetic Architecture of Gene Expression in Human Liver , 2008, PLoS biology.

[70]  N. Makridakis,et al.  PCR-free method detects high frequency of genomic instability in prostate cancer , 2009, Nucleic acids research.

[71]  K. Mimori,et al.  A platinum agent resistance gene, POLB, is a prognostic indicator in colorectal cancer , 2009, Journal of surgical oncology.

[72]  M. Rubin,et al.  Predisposition for TMPRSS2-ERG Fusion in Prostate Cancer by Variants in DNA Repair Genes , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[73]  Mickael Guedj,et al.  Variants of the xeroderma pigmentosum variant gene (POLH) are associated with melanoma risk. , 2009, European journal of cancer.

[74]  Zhigang Guo,et al.  Human DNA polymerase β polymorphism, Arg137Gln, impairs its polymerase activity and interaction with PCNA and the cellular base excision repair capacity , 2009, Nucleic acids research.

[75]  Gurpreet W. Tang,et al.  Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes , 2009, Nature.

[76]  P. Johnston,et al.  Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy , 2010, Oncogene.

[77]  Daniel Zelterman,et al.  DNA polymerase β is critical for mouse meiotic synapsis , 2010, The EMBO journal.

[78]  D. Zelterman,et al.  DNA polymerase beta is critical for genomic stability of sperm cells. , 2011, DNA repair.

[79]  Benjamin J. Raphael,et al.  Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.

[80]  N. Makridakis,et al.  Systematic biochemical analysis of somatic missense mutations in DNA polymerase β found in prostate cancer reveal alteration of enzymatic function , 2011, Human mutation.

[81]  A. Sarasin,et al.  Both XPA and DNA polymerase eta are necessary for the repair of doxorubicin-induced DNA lesions. , 2012, Cancer letters.